T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors

Cancer Research

Volumn 59, Issue 5, 1999, Pages 1071-1079

  Marzo, Amanda L ^a   Lake, Richard A ^a   Robinson, Bruce W S ^a   Scott, Bernadette ^a  

^a PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; GENETIC TRANSFECTION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SOLID TUMOR; TRANSGENIC MOUSE; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CLONE CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MHC CLASS I; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MESOTHELIOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033105362     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Restifo, N. P., Kawakami, Y., Marincola, F., Shamamian, P., Taggarse, A., Esquivel, F., and Rosenberg, S. A. Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I. J. Immunother., 14: 182-190, 1993.
2. Cohen, E. P., and Kim, T. S. Neoplastic cells that express low levels of MHC class I determinants escape host immunity. Semin. Cancer Biol., 5: 419-428, 1994.
3. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. Costimulation of antitumor immunity by the B7 counteneceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71: 1093-1102, 1992.
4. Townsend, S. E., and Allison, J. P. Tumor rejection after direct constimulation of CD8+ T cells by B7-transfected melanoma cells. Science (Washington DC), 259: 368-370, 1993.
5. Fitzpatnck, D. R., Bielefeldt, O. H., Himbeck, R. P., Jarnicki, A. G., Marzo, A. L., and Robinson, B. W. Transforming growth factor-β: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma. Growth Factors. 11: 29-44, 1994.
6. Krishnan, L., Menu, E., Chaouat, G., Talwar, G. P., and Raghupathy, R. In vitro and in vivo immunosuppressive effects of supernatants from human choriocarcinoma cell lines. Cell Immunol., 138: 313-325, 1991.
7. Singh, S., Ross, S. R., Acena, M., Rowley, D. A., and Schreiber, H. Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J. Exp. Med., 175: 139-146, 1992.
8. Onrust, S. V., Hartl, P. M., Rosen, S. D., and Hanahan, D. Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice. J. Clin. Invest., 97: 54-64, 1996.
9. Van den Eynde, B. J., and Boon, T. Tumor antigens recognized by T lymphocytes. Int. J. Clin. Lab. Res., 27: 81-86, 1997.
10. Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Gene expression profiles in normal and cancer cells. Science (Washington DC), 276: 1268-1272, 1997.
11. Topalian, S. L., and Rosenberg, S. A. Tumor-infiltrating lymphocytes: evidence for specific immune reaclions against growing cancers in mice and humans. Important Adv. Oncol., 1990: 19-41, 1990.
12. Melief, C. J., and Kast, W. M. T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes. Immunol. Rev., 145: 167-177, 1995.
13. Ramarathinam, L., Sarma, S., Marie, M., Zhao, M., Yang, G., Chen, L., and Liu, Y. Multiple lineages of tumors express a common tumor antigen, PIA, but they are not cross-protected. J. Immunol., 155: 5323-5329, 1995.
14. Goedegebuure, P. S., and Eberlein, T. J. The role of CD4+ tumor-infiltrating lymphocytes in human solid tumors. Immunol. Res., 14: 119-131, 1995.
15. Fearon, E. R., Pardoll, D. M., Itaya, T., Golumbek, P., Levitsky, H. I., Simons, J. W., Karasuyama, H., Vogelstein, B., and Frost, P. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell, 60: 397-403, 1990.
16. Ostrand, R. S., Clements, V. K., Thakur, A., and Cole, G. A. Transfection of major histocompatibility complex class I and class II genes causes tumour rejection. J. Immunogenet., 16: 343-349, 1989.
17. Morgan, D. J., Liblau, R., Scotlt, B., Fleck, S., McDevitt, H. O., Sarvetnick, N., Lo, D., and Sherman, L. A. CDS(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol., 157: 978-983, 1996.
18. Scott, B., Liblau, R., Degermann, S., Marconi, L. A., Ogata, L., Caton, A. J., McDevitt, H. O., and Lo, D. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity, 1: 73-83, 1994.
19. Davis, M. R., Manning, L. S., Whitaker, D., Garlepp, M. J., and Robinson, B. W. Establishment of a murine model of malignant mesothehoma. Int. J. Cancer. 52: 881-886, 1992.
20. Leong, C. C., Marley, J. V., Loh, S., Robinson, B. W., and Garlepp, M. J. The induction of immune responses 10 murine malignant mesothelioma by IL-2 gene transfer. Immunol. Cell Biol., 75: 356-359, 1997.
21. Lo, D., Freedman, J., Hesse, S., Palmiter, R. D. Brinster, R. L., and Sherman, L. A. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur. J. Immunol., 22: 1013-1022, 1992.
22. Howell, S. B., Dean, J. H., and Law, L. W. Defects in cell-mediated immunity during growth of a syngeneic simian virus-induced tumor. Int. J. Cancer, 152: 152-169, 1975.
23. Lyons, A. B., and Parish, C. R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods. 171: 131-137, 1994.
24. Kurts, C., Carbone, F. R., Barnden, M., Blanas, E., Allison, J., Heath, W. R., and Miller, J. F. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self- antigens and favors autoimmunity. J. Exp. Med., 186: 2057-2062, 1997.
25. Knuth, A., Wolfel, T., Klehmann, E., Boon, T., and Meyer zum Buschenfelde, K. H. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc. Natl. Acad. Sci. USA, 86: 2804-2808, 1989.
26. Speiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall, F. K., Odermatt, B., Hanahan, D., Zinkernagel, R. M., and Ohashi, P. S. Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J. Exp. Med., 186: 645-653, 1997.
27. Wang, M., Bronte, V., Chen, P. W., Gritz., L., Panicali, D., Rosenherg, S. A., and Restifo, N. P. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J. Immunol., 154: 4685-4692, 1995.
28. Ye, X., McCarriek, J., Jewett, L., and Knowles, B. B. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenie mice. Proc. Natl. Acad. Sci. USA, 91: 3916-3920, 1994.
29. Zhou, F., Rouse, B. T., and Huang, L. Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: a model study. Cancer Res., 52; 6287-6291, 1992.
30. Jenkins, M. K., and Schwartz, R. H. Antigen presentation by chemically modified splenoeytes induces antigen-.specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med., 165: 302-319, 1987.
31. Webb, S., Morris, C., and Sprent, J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 63: 1249-1256, 1990.
32. Sha, W. C., Nelson, C. A., Newberry, R. D., Kranz, D. M., Russell, J. H., and Loh, D. Y. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature (Lond.), 335: 271-274, 1988.
33. Wick, M., Dubey, P., Koeppen, H., Siegel, C. T., Fields, P. E., Chen, L., Bluestone, J. A., and Schreiber, H. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy. J. Exp. Med., 186: 229-238, 1997.
34. Bielefeldt-Ohmann, H., Fitzpatrick, D. R., Marzo, A. L., Jarnicki, A. G., Himbeck, R. P., Davis, M. R., Manning, L. S., and Robinson, B. W. S. Patho- and immunobiology of malignant mesothelioma: characterisation of tumor infiltrating T leukocytes and cytokine production in a murine model. Cancer Immunol. Immunother., 39: 347-359, 1994.
35. Jarnicki, A. G., Fitzpatrick, D. R., Robinson, B. W., and Bielefeldt, O. H. Altered CD3 chain and cytokine gene expression in tumor infiltrating T lymphocytes during the development of mesothelioma. Cancel Lett., 103: 1-9, 1996.
36. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., and Gately, M. K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med., 178: 1223-1230, 1993.
37. Darrow, T. L., Abdel Wahab, Z., Quinn Allen, M. A., and Seigler, H. F. Recognition and lysis of human melanoma by a CD3+, CD4+, CD8-T-cell clone restricted by HLA-A2. Cell Immunol., 172: 52-59, 1996.
38. Awwad, M., and North, R. J. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity. J. Exp. Med., 168: 2193-2206, 1988.
39. Bradley, B. J., Haskins, K., La Rosa, F. G., and Lafferty, K. J. CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone. Diabetes, 41: 1603-1608, 1992.
40. Friedman, A., Reshef, T., and Cohen, I. R. Induction of experimental autoimmune encephalomyelitis by native myelin basic protein-activated T lymphocyte lines. Eur. J. Immunol., 22: 279-282, 1992.
41. Bennett, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F., and Heath, W. R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (Lond.), 393: 478-480, 1998.
42. Ridge, J. P., Di Rosa, F., and Matzinger, P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T- helper and a T-killer cell. Nature (Lond.), 393: 474-478, 1998.
43. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R., and Melief, C. J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature (Lond.), 393: 480-483, 1998.